CliffBio
small molecule

CO-GESIC

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Loss of exclusivity—loss of exclusivity
CompanyUCB →See this company's full patent-cliff portfolio

Drug detail

Brand nameCO-GESIC
Active ingredientACETAMINOPHEN; HYDROCODONE BITARTRATE
Strength500MG;5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 1982
Marketing statusDISCN

More from UCB

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CO-GESIC patent cliff — loss of exclusivity — | CliffBio